Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, Guangdong, China.
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109119. doi: 10.1016/j.drugalcdep.2021.109119. Epub 2021 Oct 10.
The impact of substance use disorders (SUD) in an Asian population has not been fully explored. We aimed to assess the risk of mortality, accident and emergency (A&E) department attendances, and hospital admissions associated with SUD in a population-based cohort study.
Patients diagnosed with SUD in public A&E departments from 2004 to 2016 (N = 8,423) were identified in the Clinical Database Analysis and Reporting System of the Hong Kong Hospital Authority and 1:1 matched to patients without SUD by propensity score (N = 6,074 in each group). Relative risks of mortality, A&E attendances and hospital admissions were assessed using Cox regression and Hurdle negative binomial regression.
Patients with SUD had higher mortality (hazard ratio=1.43; 95% confidence interval [CI]=1.26-1.62) and more often died from poisoning or toxicity and injuries. The odds ratio (OR) for A&E attendances and all-cause hospital admissions associated with SUD were 2.80 (95% CI=2.58-3.04) and 3.54 (95% CI=3.26-3.83), respectively. The impact of SUD on the above outcomes was greatest among school-aged individuals (≤ 21 years) and decreased with age. The relative risk of mental disorder-related hospital admissions was much higher than that for infections, respiratory diseases, and cardiovascular diseases. In patients with SUD, ketamine and amphetamine use were associated with increased A&E attendances than opioid use.
SUD was associated with increased mortality, A&E attendances and hospital admissions, especially in school-aged individuals. Our findings suggest prioritising early treatment and preventive interventions for school-aged individuals and focusing on the management of comorbid mental disorders and the use of ketamine and amphetamine.
物质使用障碍(SUD)在亚洲人群中的影响尚未得到充分探索。我们旨在通过一项基于人群的队列研究评估 SUD 与死亡率、急诊(A&E)就诊次数和住院次数相关的风险。
在香港医院管理局的临床数据库分析和报告系统中,确定了 2004 年至 2016 年期间在公立 A&E 部门诊断为 SUD 的患者(N=8423),并通过倾向评分对其进行了 1:1 匹配(每组 6074 例患者)。使用 Cox 回归和障碍负二项回归评估死亡率、A&E 就诊次数和住院次数的相对风险。
SUD 患者的死亡率更高(风险比=1.43;95%置信区间[CI]为 1.26-1.62),且更常死于中毒或毒性和损伤。与 SUD 相关的 A&E 就诊次数和全因住院次数的比值比(OR)分别为 2.80(95%CI=2.58-3.04)和 3.54(95%CI=3.26-3.83)。SUD 对上述结果的影响在学龄个体(≤21 岁)中最大,并随年龄增长而降低。与感染、呼吸道疾病和心血管疾病相比,精神障碍相关住院的相对风险要高得多。在 SUD 患者中,与阿片类药物使用相比,使用氯胺酮和苯丙胺与 A&E 就诊次数增加相关。
SUD 与死亡率、A&E 就诊次数和住院次数增加相关,尤其是在学龄个体中。我们的研究结果表明,应优先为学龄个体提供早期治疗和预防干预,并注重管理共病精神障碍和氯胺酮及苯丙胺的使用。